Cipro (ciprofloxacin hydrochloride) NDC 50419-758

NDC codes

FDA NDC Directory

Product NDC (as listed)50419-758Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50419-0758Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50419-758-01	50419075801	100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-758-01)Marketed from Oct 22, 1987

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cipro
Generic name (nonproprietary): ciprofloxacin hydrochloride
Active ingredients: Ciprofloxacin hydrochloride — 250 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bayer HealthCare Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 019537
Marketing start: Oct 22, 1987
Listing expires: Dec 31, 2027
Other FDA classes: Cytochrome P450 1A2 Inhibitors (Mechanism)Fluoroquinolones (Chemical structure)
Identifiers: Product ID 50419-758_1b112839-6cf0-466a-9188-86fc5b1549f9SPL ID 1b112839-6cf0-466a-9188-86fc5b1549f9SPL set ID 888dc7f9-ad9c-4c00-8d50-8ddfd9bd27c0RxCUI 197511, 205769, 205770, 213224, 213226, 309308, 309309, 309310UNII 4BA73M5E37UPC 0350419754019, 0350419758017
Pharmacologic class: Fluoroquinolone Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450419075801 followed by a unit qualifier and the quantity

Package 50419-0758-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Mar 2, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

CIPRO is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: • Skin and Skin Structure Infections ( 1.1 ) • Bone and Joint Infections ( 1.2 ) • Complicated Intra-Abdominal Infections ( 1.3 ) • Infectious Diarrhea ( 1.4 ) • Typhoid Fever (Enteric Fever) ( 1.5 ) • Uncomplicated Cervical and Urethral Gonorrhea ( 1.6 ) • Inhalational Anthrax post-exposure in adult and pediatric patients ( 1.7) • Plague in adult and pediatric patients ( 1.8 ) • Chronic Bacterial Prostatitis ( 1.9 ) • Lower Respiratory Tract Infections ( 1.10 ) • Acute Exacerbation of Chro…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 019537

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 019537
Product	Strength	Form · route	Labeler	Product NDC
Ciprociprofloxacin hydrochloride	Ciprofloxacin hydrochloride 500 mg/1	Tablet, Film coatedOral	Bayer HealthCare Pharmaceuticals Inc.	50419-754